BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 26369868)

  • 1. Anti-idiotypic antibody: A new strategy for the development of a growth hormone receptor antagonist.
    Lan H; Zheng X; Khan MA; Li S
    Int J Biochem Cell Biol; 2015 Nov; 68():101-8. PubMed ID: 26369868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activation and differential signalling of the growth hormone receptor induced by pGH or anti-idiotypic monoclonal antibodies in primary rat hepatocytes.
    Li W; Lan H; Liu H; Fu Z; Yang Y; Han W; Guo F; Liu Y; Zhang H; Liu J; Zheng X
    Mol Cell Endocrinol; 2013 Aug; 376(1-2):51-9. PubMed ID: 23769824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential intracellular signalling properties of the growth hormone receptor induced by the activation of an anti-GHR antibody.
    Lan H; Li W; Fu Z; Yang Y; Wu T; Liu Y; Zhang H; Cui H; Li Y; Hong P; Liu J; Zheng X
    Mol Cell Endocrinol; 2014 Jun; 390(1-2):54-64. PubMed ID: 24755421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of a novel GHR antibody antagonist, GF185.
    Sun F; Liu Y; Sun H; Tian B
    Int J Biol Macromol; 2015 Aug; 79():864-70. PubMed ID: 26051340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Internal image anti-idiotypic antibody: A new strategy for the development a new category of prolactin receptor (PRLR) antagonist.
    Lan H; Hong P; Li R; L S; Anshan S; Li S; Zheng X
    Mol Immunol; 2017 Jul; 87():86-93. PubMed ID: 28412548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
    Lincoln DT; Singal PK; Al-Banaw A
    Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A conformationally sensitive GHR [growth hormone (GH) receptor] antibody: impact on GH signaling and GHR proteolysis.
    Jiang J; Wang X; He K; Li X; Chen C; Sayeski PP; Waters MJ; Frank SJ
    Mol Endocrinol; 2004 Dec; 18(12):2981-96. PubMed ID: 15345746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Characterization of a Novel Anti-idiotypic Monoclonal Antibody to Growth Hormone, Which Can Mimic Physiological Functions of Growth Hormone in Primary Porcine Hepatocytes.
    Lan HN; Jiang HL; Li W; Wu TC; Hong P; Li YM; Zhang H; Cui HZ; Zheng X
    Asian-Australas J Anim Sci; 2015 Apr; 28(4):573-83. PubMed ID: 25656185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion of animal growth with a monoclonal antibody specific to growth hormone receptor.
    Wang BS; Lumanglas AA; Bona CA; Moran TM
    Mol Cell Endocrinol; 1996 Feb; 116(2):223-6. PubMed ID: 8647323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of a Growth Hormone Receptor/Prolactin Receptor Bispecific Antibody Antagonist Which Exhibited Anti-Cancer Activity.
    Chen X; Wu D; Zheng Y; Liu X; Wang J
    Front Pharmacol; 2020; 11():598423. PubMed ID: 33362552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory GH receptor extracellular domain monoclonal antibodies: three-dimensional epitope mapping.
    Jiang J; Wan Y; Wang X; Xu J; Harris JM; Lobie PE; Zhang Y; Zinn KR; Waters MJ; Frank SJ
    Endocrinology; 2011 Dec; 152(12):4777-88. PubMed ID: 21990310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular signaling transduction pathways triggered by a well-known anti-GHR monoclonal antibody, Mab263, in vitro and in vivo.
    Lan H; Li W; Jiang H; Yang Y; Zheng X
    Int J Mol Sci; 2014 Nov; 15(11):20538-54. PubMed ID: 25391041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a new anti-prolactin receptor (PRLR) antibody, F56, which can serve as a PRLR antagonist.
    Cui H; Ma YZ; Wang Y; Song M; Zhang H
    Int J Biol Macromol; 2017 Feb; 95():1223-1227. PubMed ID: 27829125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody against human growth hormone receptor.
    Lattuada D; Casnici C; Perego C; Testorelli C; Berrini A; Tonon G; Marelli O
    Hybridoma; 2000 Apr; 19(2):177-83. PubMed ID: 10868799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterisation of a novel inhibitory anti-GH monoclonal antibody.
    Lu M; Buckley C; Wang Y; Langley RJ; Perry JK
    J Mol Endocrinol; 2024 Jan; 72(1):. PubMed ID: 37855323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transduction pathways of GH in ovine mammary acini involving regulated and functional growth hormone receptors.
    Chun EY; Belair L; Jolivet G; Djiane J; Jammes H
    Growth Factors; 2005 Mar; 23(1):55-66. PubMed ID: 16019427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope map for a growth hormone receptor agonist monoclonal antibody, MAb 263.
    Wan Y; Zheng YZ; Harris JM; Brown R; Waters MJ
    Mol Endocrinol; 2003 Nov; 17(11):2240-50. PubMed ID: 12907759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear translocation and retention of growth hormone.
    Mertani HC; Raccurt M; Abbate A; Kindblom J; Törnell J; Billestrup N; Usson Y; Morel G; Lobie PE
    Endocrinology; 2003 Jul; 144(7):3182-95. PubMed ID: 12810575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the growth hormone (GH) receptor transmembrane domain in receptor predimerization and GH-induced activation.
    Yang N; Wang X; Jiang J; Frank SJ
    Mol Endocrinol; 2007 Jul; 21(7):1642-55. PubMed ID: 17456794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signaling pathways in the Pro-B Ba/F3 cell line.
    Baixeras E; Jeay S; Kelly PA; Postel-Vinay MC
    Endocrinology; 2001 Jul; 142(7):2968-77. PubMed ID: 11416018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.